Dexcom Income Statement
DXCM / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Dexcom reported $4.7B in revenue and $836M in net income for FY2025. Revenue has grown at a 34.1% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.7B | $4.0B | $3.6B | $1.9B | $2.4B | $1.9B | $1.5B | $1.0B | $142.3M | $116.2M | $72.8M | $47.1M | $29.6M | $99.9M | $76.3M |
| Cost of Revenue | $1.9B | $1.6B | $1.3B | $646.6M | $768.0M | $646.6M | $544.5M | $367.7M | $123.6M | $82.9M | $59.9M | $82.9M | $59.9M | $53.3M | $40.4M |
| Gross Profit | $2.8B | $2.4B | $2.3B | $1.3B | $1.7B | $1.3B | $931.5M | $663.9M | $278.4M | $176.3M | $100.1M | $176.3M | $100.1M | $46.6M | $35.9M |
| SG&A Expense | $1.3B | $1.3B | $1.2B | $618.2M | $810.5M | $618.2M | $515.7M | $432.8M | $198.0M | $128.4M | $84.2M | $128.4M | $84.2M | $64.0M | $51.1M |
| R&D Expense | $599.1M | $552.4M | $505.8M | $359.9M | $517.1M | $359.9M | $273.5M | $199.7M | $137.5M | $69.4M | $44.8M | $69.4M | $44.8M | $38.3M | $29.6M |
| Operating Income | $911.8M | $600.0M | $597.7M | $299.5M | $265.8M | $299.5M | $142.3M | -$186.3M | -$57.1M | -$21.5M | -$28.9M | -$21.5M | -$28.9M | -$55.7M | -$44.8M |
| Interest Expense | $14.3M | $14.9M | $16.4M | $17.7M | $18.8M | $17.7M | $60.3M | $22.7M | $400.0K | $800.0K | $900.0K | $800.0K | $900.0K | $200.0K | $0 |
| Income Tax | $252.1M | $132.8M | $168.9M | -$251.8M | $39.9M | -$251.8M | $3.1M | $600.0K | $100.0K | $100.0K | $0 | $100.0K | $0 | -$1.3M | $0 |
| Net Income | $836.3M | $576.2M | $541.5M | $549.7M | $216.9M | $549.7M | $101.1M | -$127.1M | -$57.6M | -$22.4M | -$29.8M | -$22.4M | -$29.8M | -$54.5M | -$44.7M |
| EPS (Basic) | $2.14 | $1.46 | $1.40 | $1.46 | $1.11 | $1.46 | $1.11 | -$0.28 | - | - | - | - | - | - | - |
| EPS (Diluted) | $2.09 | $1.42 | $1.30 | $1.33 | $1.10 | $1.33 | $1.10 | -$0.28 | -$0.72 | -$0.30 | -$0.42 | -$0.79 | -$0.68 | -$0.97 | -$1.21 |
| Shares Outstanding | 384.8M | 390.7M | 385.4M | 388.0M | 96.1M | 96.1M | 91.6M | 87.0M | 84.6M | 81.7M | 77.3M | 72.5M | 69.5M | 67.5M | 62.1M |
| Gross Margin | 60.1% | 60.5% | 63.2% | 66.4% | 68.6% | 66.4% | 63.1% | 64.4% | 195.6% | 151.7% | 137.5% | 374.3% | 338.2% | 46.7% | 47.0% |
| Operating Margin | 19.6% | 14.9% | 16.5% | 15.5% | 10.9% | 15.5% | 9.6% | -18.1% | -40.1% | -18.5% | -39.7% | -45.6% | -97.6% | -55.8% | -58.7% |
| Profit Margin | 17.9% | 14.3% | 14.9% | 28.5% | 8.9% | 28.5% | 6.9% | -12.3% | -40.5% | -19.3% | -40.9% | -47.6% | -100.7% | -54.5% | -58.6% |